Mackenzie Financial’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
+8,003
| New | +$260K | ﹤0.01% | 1456 |
|
|
2025
Q1 | – | Sell |
-5,071
| Closed | -$415K | – | 1761 |
|
|
2024
Q4 | $415K | Sell |
5,071
-303
| -6% | -$24.8K | ﹤0.01% | 1250 |
|
|
2024
Q3 | $614K | Buy |
5,374
+2,004
| +59% | +$229K | ﹤0.01% | 970 |
|
|
2024
Q2 | $254K | Sell |
3,370
-675
| -17% | -$51K | ﹤0.01% | 1240 |
|
|
2024
Q1 | $276K | Buy |
4,045
+102
| +3% | +$6.97K | ﹤0.01% | 1203 |
|
|
2023
Q4 | $248K | Sell |
3,943
-1,813
| -31% | -$114K | ﹤0.01% | 1239 |
|
|
2023
Q3 | $273K | Hold |
5,756
| – | – | ﹤0.01% | 1171 |
|
|
2023
Q2 | $283K | Buy |
+5,756
| New | +$283K | ﹤0.01% | 1188 |
|
|
2023
Q1 | – | Sell |
-4,479
| Closed | -$215K | – | 1588 |
|
|
2022
Q4 | $215K | Buy |
+4,479
| New | +$215K | ﹤0.01% | 1219 |
|